These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1001827)

  • 21. Preparation of a Clostridium chauvoei antigen and determination of protective immunity by plate agglutination test.
    Claus KD; Macheak ME
    Am J Vet Res; 1972 May; 33(5):1045-52. PubMed ID: 5023042
    [No Abstract]   [Full Text] [Related]  

  • 22. The development of an enzyme-linked immunosorbent assay for measuring the potency of vaccines containing Clostridium chauvoei antigens.
    Crichton R; Solomon J; Barton AM
    Biologicals; 1990 Jan; 18(1):49-54. PubMed ID: 2317354
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of a multicomponent standard for clostridial vaccines.
    Gray AK
    Dev Biol Stand; 1976; 32():245-50. PubMed ID: 187507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Progress in the replacement of animal experiments in the quality control of clostridial vaccines].
    Cussler K; Borrmann E; Werner E
    Dtsch Tierarztl Wochenschr; 2002 Apr; 109(4):172-7. PubMed ID: 11998369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An international survey of clostridial sera and vaccines.
    Davidson I
    Dev Biol Stand; 1976; 32():3-14. PubMed ID: 187508
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Responses of hamsters and guinea pigs to antigens of Clostridium chauvoei.
    Macheak ME; Claus KD
    Am J Vet Res; 1972 May; 33(5):1039-44. PubMed ID: 5023041
    [No Abstract]   [Full Text] [Related]  

  • 27. Prevention of Blackleg by an immunogen of Clostridium chauvoei.
    Ontiveros Corpus Mde L; Hernández Andrade L; López Mendez J; Tenorio Gutierrez V
    Ann N Y Acad Sci; 2008 Dec; 1149():303-5. PubMed ID: 19120234
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunological differences between strains of Clostridium chauvoei.
    Kerry JB
    Res Vet Sci; 1967 Jan; 8(1):89-97. PubMed ID: 6067707
    [No Abstract]   [Full Text] [Related]  

  • 29. Identifying and purifying protective immunogens from cultures of Clostridium chauvoei.
    Hauer PJ; Rosenbusch RF
    Dev Biol Stand; 1996; 86():332. PubMed ID: 8785972
    [No Abstract]   [Full Text] [Related]  

  • 30. Potency testing Clostridium novyi-containing bacterins: comparison of immunologic response in guinea pigs and sheep.
    Macheak ME; Claus KD; Maloy SE
    Am J Vet Res; 1972 Jun; 33(6):1201-8. PubMed ID: 5022400
    [No Abstract]   [Full Text] [Related]  

  • 31. A serological potency assay for Clostridium chauvoei.
    Hauer PJ; Whitaker MS; Henry LA
    Dev Biol Stand; 1996; 86():331. PubMed ID: 8785971
    [No Abstract]   [Full Text] [Related]  

  • 32. Potency testing of Cl. sordellii bacterin-toxoids by means of a mouse protection test.
    Haas HF
    Dev Biol Stand; 1976; 32():167-72. PubMed ID: 1001830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Isolation and identification in Senegal of the most immunogenic protein soluble antigen of a Clostridium chauvoei strain].
    Mbengue MB
    Bull Soc Pathol Exot; 2008 Feb; 101(1):3-4. PubMed ID: 18431995
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a cell culture assay for the quantitative determination of vaccination-induced antibodies in rabbit sera against Clostridium perfringens epsilon toxin and Clostridium novyi alpha toxin.
    Borrmann E; Schulze F; Cussler K; Hänel I; Diller R
    Vet Microbiol; 2006 Apr; 114(1-2):41-50. PubMed ID: 16361070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The use of the toxin binding inhibition test for potency testing of Clostridium novyi type B alpha toxoid vaccines].
    Luick K; Gottschaldt J; Schulze F; Werner E; Erler W; Borrmann E
    Dtsch Tierarztl Wochenschr; 2002 Apr; 109(4):178-82. PubMed ID: 11998370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protection against enteric colibacillosis in pigs suckling orally vaccinated dams: evidence for pili as protective antigens.
    Moon HW
    Am J Vet Res; 1981 Feb; 42(2):173-7. PubMed ID: 6114691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use and standardization of multicomponent veterinary vaccines.
    Walker PD; Batty I
    Dev Biol Stand; 1986; 65():227-36. PubMed ID: 3549398
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Demonstration of common antigens on cell surface of Clostridium chauvoei and C. septicum by indirect-immunofluorescence assay.
    Hamaoka T; Terakado N
    J Vet Med Sci; 1994 Apr; 56(2):371-3. PubMed ID: 8075228
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enzyme-linked immunosorbent assay for evaluation of immunity in mice vaccinated with blackleg vaccine.
    Hamaoka T; Mori Y; Terakado N
    Nihon Juigaku Zasshi; 1990 Feb; 52(1):167-70. PubMed ID: 2313947
    [No Abstract]   [Full Text] [Related]  

  • 40. A mouse model to estimate the potency of the diphtheria component in combined vaccines.
    Kreeftenberg JG; van der Gun J; Marsman FR; van Asten JA; Sekhuis VM; Hendriksen CF
    Dev Biol Stand; 1986; 64():21-4. PubMed ID: 2878846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.